Unavailable
Unavailable
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/11/2024 | Sector Weight | KeyBanc Capital Markets | |
| 6/21/2024 | $15.00 | Buy | BTIG Research |
| 3/6/2024 | $13.00 | Buy | HSBC Securities |
| 2/27/2024 | $11.50 | Hold → Buy | Deutsche Bank |
| 2/20/2024 | $15.00 | Buy | Guggenheim |
| 2/20/2024 | $15.00 | Outperform | Leerink Partners |
| 2/20/2024 | $15.00 | Buy | UBS |
| 2/20/2024 | $14.00 | Buy | BofA Securities |
LOUISVILLE, Ky., Sept. 30, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services ("BrightSpring" or "the Company") (NASDAQ:BTSG), a leading provider of home- and community-based health services for complex populations, today announced that Dr. Steve Miller was appointed as a Class II member of the Board of Directors. Dr. Miller will also serve as a member of the Board's Audit Committee and as the chair of the Board's Quality & Compliance and Governance Committee. As a nationally recognized advocate for greater access, affordability, and excellence in healthcare, Dr. Miller brings decades of experience to the Company as a medical researcher, clinician, and administrator across numerous hea
LOUISVILLE, Ky., April 26, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG), a leading provider of home and community-based health services for complex populations, today announced that on April 24, 2024, BrightSpring appointed Timothy A. Wicks as a new member of the Board of Directors. Mr. Wicks will assume his new role effective immediately, bringing the Company's total Board of Directors to seven members, including two independent directors. Mr. Wicks brings over 20 years of executive leadership experience in the healthcare industry to BrightSpring's Board of Directors, including his most recent role as Executive Vice President
KeyBanc Capital Markets initiated coverage of BrightSpring Health Services with a rating of Sector Weight
BTIG Research initiated coverage of BrightSpring Health Services with a rating of Buy and set a new price target of $15.00
HSBC Securities initiated coverage of BrightSpring Health Services with a rating of Buy and set a new price target of $13.00
8-K - BrightSpring Health Services, Inc. (0001865782) (Filer)
10-Q - BrightSpring Health Services, Inc. (0001865782) (Filer)
8-K - BrightSpring Health Services, Inc. (0001865782) (Filer)
LOUISVILLE, Ky., Nov. 21, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG) announced today that Company management will participate at two upcoming virtual investor conferences. BTIG Virtual Digital Health Forum Panel on Monday, November 25th at 9:00AM ET Bank of America Virtual Home Care Conference 2024Fireside Chat on Tuesday, December 10th at 2:10PM ET A live and archived webcast of the Bank of America Home Care Conference Fireside Chat will be available on the "Event & Presentations" section of the BrightSpring investor relations website at https://ir.brightspringhealth.com/. About BrightSpring Health Services Brig
LOUISVILLE, Ky., Nov. 06, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services ("BrightSpring" or "BrightSpring Health Services") (NASDAQ:BTSG) is proud that CareMed, a BrightSpring company and leading independent Specialty Pharmacy, was selected by Eisai to be the national specialty pharmacy provider for Leqembi®, a cutting-edge treatment for Alzheimer's disease. "We're proud of the work CareMed is doing with manufacturers and prescribers to improve and extend the lives of patients living with mild cognitive impairment and dementia, bringing more treatment options to Alzheimer's disease," said BrightSpring's President and CEO, Jon Rousseau. "CareMed's partnership with Eisai shows their
LOUISVILLE, Ky., Nov. 01, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG), a leading provider of home and community-based health services for complex populations, today announced financial results for the third quarter ended September 30, 2024, and increases 2024 revenue and Adjusted EBITDA1 guidance. Financial Highlights Net Revenue of $2,907 million, up 28.8% compared to $2,257 million in the third quarter of 2023.Net loss of $9.0 million, compared to net loss of $130.1 million in the third quarter of 2023.Adjusted EBITDA1 of $151 million, up 15.7% versus $131 million in the third quarter of 2023Increased 2024 Revenue and Adju
SC 13G - BrightSpring Health Services, Inc. (0001865782) (Subject)
SC 13G - BrightSpring Health Services, Inc. (0001865782) (Subject)
SC 13G - BrightSpring Health Services, Inc. (0001865782) (Subject)
4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)
4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)
4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)
4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)
3 - BrightSpring Health Services, Inc. (0001865782) (Issuer)
4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)
LOUISVILLE, Ky., Nov. 01, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG), a leading provider of home and community-based health services for complex populations, today announced financial results for the third quarter ended September 30, 2024, and increases 2024 revenue and Adjusted EBITDA1 guidance. Financial Highlights Net Revenue of $2,907 million, up 28.8% compared to $2,257 million in the third quarter of 2023.Net loss of $9.0 million, compared to net loss of $130.1 million in the third quarter of 2023.Adjusted EBITDA1 of $151 million, up 15.7% versus $131 million in the third quarter of 2023Increased 2024 Revenue and Adju
LOUISVILLE, Ky., Oct. 01, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG) announced today that it plans to release its third quarter 2024 financial results on Friday, November 1, 2024, prior to the Company's earnings conference call, which will be held at 8:30 a.m. ET on the same day. To participate in the conference call, please register here before the 8:30 a.m. ET start. A live and archived webcast of the call will be available on the Company's investor relations website at https://ir.brightspringhealth.com under the "Events & Presentations" section, where related presentation materials will be posted prior to the conference
LOUISVILLE, Ky., Sept. 03, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services ("BrightSpring" or "the Company") (NASDAQ:BTSG), a leading provider of home and community-based health services for complex populations, today announced that it completed the acquisition of the assets of North Central Florida Hospice, Inc. and Haven Medical Group, LLC (collectively "Haven Hospice"), a Florida-based company holding a Certificate of Need (CON) for comprehensive hospice care services in 18 counties in north central Florida, effective September 1, 2024. "We are excited to welcome Haven Hospice into BrightSpring, expanding our existing hospice services into the CON state of Florida," said Bright
The company announced a definitive agreement to acquire the assets of North Central Florida Hospice, Inc. and Haven Medical Group, LLC (collectively "Haven Hospice"), a Florida-based company holding a Certificate of Need (CON) for comprehensive hospice care services in 18 counties in north central Florida. otal consideration for the acquisition is $60 million, with $15 million in cash at close, $30 million in Company equity at close, and an additional $15 million in a seller note payable four years after closing.
BTIG analyst David Larsen initiates coverage on BrightSpring Health (NASDAQ:BTSG) with a Buy rating and announces Price Target of $15.